{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMARK1, a member of the microtubule affinity‐regulating kinase family, plays a pivotal role in controlling cell polarity and cytoskeletal dynamics. Its activity is integrated into key signal transduction cascades, such as the Hippo‐YAP pathway, where upstream regulation by LKB1 is thought to influence the localization of polarity determinants and core kinase activity, thereby contributing to tumor suppression. In addition, genome‐wide association studies have identified genetic variants near MARK1 that are linked to substance dependence disorders, hinting at a broader role in neural function and behavior."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGenetic analyses in neurodevelopment have further underscored the importance of MARK1. Association studies in autism spectrum disorders have revealed that risk alleles within MARK1 correlate with altered dendritic transport and axon–dendrite specification, suggesting that changes in MARK1 expression may affect neuronal connectivity and cognitive evolution. Complementary structural studies, including high-resolution crystal structures of the catalytic and ubiquitin-associated (UBA) domains of MARK1, have provided critical insights into its enzymatic mechanisms and substrate interactions. Moreover, MARK1’s ability to phosphorylate microtubule-associated proteins such as tau underlines its role in modulating microtubule stability—a function essential for proper brain development and neuronal migration."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe regulation of MARK1 activity is achieved in part through intramolecular autoinhibitory mechanisms. Studies have demonstrated that the C-terminal kinase-associated (KA1) domain of MARK1 binds its own kinase domain—blocking substrate access—and that this autoinhibition is alleviated upon binding to anionic phospholipids at the membrane, provided an additional targeting signal is present. This nuanced mode of regulation not only has implications in spatial and temporal control of MARK1 activation but also in disease contexts. For instance, in colorectal cancer models, miR-23a has been shown to downregulate MARK1, thereby promoting cell proliferation and migration; restoration of MARK1 expression mitigates these oncogenic effects, making the MARK1 pathway a promising target for therapeutic intervention."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Morvarid Mohseni, Jianlong Sun, Allison Lau, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb2884"}], "href": "https://doi.org/10.1038/ncb2884"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24362629"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24362629"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Penelope A Lind, Stuart Macgregor, Jacqueline M Vink, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Twin Res Hum Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1375/twin.13.1.10"}], "href": "https://doi.org/10.1375/twin.13.1.10"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20158304"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20158304"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Gilles Maussion, Jérôme Carayol, Aude-Marie Lepagnol-Bestel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Convergent evidence identifying MAP/microtubule affinity-regulating kinase 1 (MARK1) as a susceptibility gene for autism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddn154"}], "href": "https://doi.org/10.1093/hmg/ddn154"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18492799"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18492799"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Alexander Marx, Chanakya Nugoor, Jens Müller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural variations in the catalytic and ubiquitin-associated domains of microtubule-associated protein/microtubule affinity regulating kinase (MARK) 1 and MARK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M604865200"}], "href": "https://doi.org/10.1074/jbc.M604865200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16803889"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16803889"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Thomas Timm, Alexander Marx, Saravanan Panneerselvam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Neurosci (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2202-9-S2-S9"}], "href": "https://doi.org/10.1186/1471-2202-9-S2-S9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19090997"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19090997"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Orly Reiner, Tamar Sapir "}, {"type": "b", "children": [{"type": "t", "text": "Mark/Par-1 marking the polarity of migrating neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Adv Exp Med Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/978-94-007-7687-6_6"}], "href": "https://doi.org/10.1007/978-94-007-7687-6_6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24243102"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24243102"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Ryan P Emptage, Mark A Lemmon, Kathryn M Ferguson "}, {"type": "b", "children": [{"type": "t", "text": "Molecular determinants of KA1 domain-mediated autoinhibition and phospholipid activation of MARK1 kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BCJ20160792"}], "href": "https://doi.org/10.1042/BCJ20160792"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27879374"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27879374"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Ryan P Emptage, Mark A Lemmon, Kathryn M Ferguson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural Basis for MARK1 Kinase Autoinhibition by Its KA1 Domain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Structure (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.str.2018.05.008"}], "href": "https://doi.org/10.1016/j.str.2018.05.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30099988"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30099988"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Xiaoli Tang, Meiyuan Yang, Zheng Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-23a promotes colorectal cancer cell migration and proliferation by targeting at MARK1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Biochim Biophys Sin (Shanghai) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/abbs/gmz047"}], "href": "https://doi.org/10.1093/abbs/gmz047"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31281935"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31281935"}]}]}]}